참고문헌
- Smith RA, Ghaneh P, Sutton R, et al (2008).Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio. J Gastrointest Surg, 12, 1422-8. https://doi.org/10.1007/s11605-008-0554-3
- Stotz M, Gerger A, Eisner F, et al (2013). Increased neutrophillymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer, 109, 416-21. https://doi.org/10.1038/bjc.2013.332
- Tanoglu A, Karagoz E, Yiyit N, Berber U (2014). Is combination of neutrophil to lymphocyte ratio and platelet lymphocyte ratio a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma? Onco Targets Ther, 7, 433-4.
- Tanoglu A, Karagoz E (2014). Predictive role of neutrophil to lymphocyte ratio in patients with advanced hepatocelluler carcinoma receiving sorafenib. Asian Pac J Cancer Prev, 15, 1063. https://doi.org/10.7314/APJCP.2014.15.2.1063
- Unal D1, Eroglu C, Kurtul N, Oguz A, Tasdemir A. (2013). Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non small cell lung cancer associated with treatment response and prognosis? Asian Pac J Cancer Prev, 14, 5237-42. https://doi.org/10.7314/APJCP.2013.14.9.5237
- Wang D, Yang JX, Cao DY, et al (2013). Preoperative neutrophillymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma. OncoTargets Ther, 6, 211-6
- Zheng YB, Zhao W, Liu B, et al (2013). The blood neutrophil-tolymphocyte ratio predicts survival in patients with advanced hepatocellular carcinoma receiving sorafenib. Asian Pac J Cancer Prev, 14, 5527-31. https://doi.org/10.7314/APJCP.2013.14.9.5527